Myrexis, Inc. Reports Second Quarter Fiscal Year 2012 Results

Published: Feb 10, 2012

SALT LAKE CITY, Feb. 9, 2012 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and distinct mechanisms of action, today reported financial results for its second fiscal quarter ended December 31, 2011.

Back to news